Tuesday, November 24, 2009

FDA panel votes against new bug-based flu vaccine

BETHESDA, Maryland-More safety data would be needed before a new type of influenza vaccine made in insect cells should get approval, federal advisers said on Thursday.
A divided committee advising the U.S. Food and Drug Administration said the new Protein Sciences Corp FluBlok vaccine appears effective among adults under age 50 but said the company has not shown that it is safe enough to be approved.
The vaccine is made using genetically engineered pieces of flu virus inserted into caterpillar cells, instead of the current method using whole virus grown in chicken eggs...

No comments:

Post a Comment